Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Han Lee

Showing results (331-340 of 350) with videos related to

Pageof 35
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 23, 2016
Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumorsJen-Chieh Lee, Sheng-Yao Su, Chun A Changou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 25, 2021
TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibitionSarah Chiang, Varshini Vasudevaraja, Jonathan Serrano, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian CancerKim Ma, Basile Tessier-Cloutier, Alon D Altman, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 2012
14-3-3 fusion oncogenes in high-grade endometrial stromal sarcomaCheng-Han Lee, Wen-Bin Ou, Adrian Mariño-Enriquez, et al.
The Journal of Pathology. Clinical Research|March 8, 2022
The impact of whole genome and transcriptome analysis (WGTA) on predictive biomarker discovery and diagnostic accuracy of advanced malignanciesBasile Tessier-Cloutier, Jasleen K Grewal, Martin R Jones, et al.
The New England Journal of Medicine|December 23, 2011
Recurrent somatic DICER1 mutations in nonepithelial ovarian cancersAlireza Heravi-Moussavi, Michael S Anglesio, S-W Grace Cheng, et al.
Nature|June 12, 2024
Obesity induces PD-1 on macrophages to suppress anti-tumour immunityJackie E Bader, Melissa M Wolf, Gian Luca Lupica-Tondo, et al.
Nature|July 9, 2024
Author Correction: Obesity induces PD-1 on macrophages to suppress anti-tumour immunityJackie E Bader, Melissa M Wolf, Gian Luca Lupica-Tondo, et al.
Cell Genomics|May 10, 2025
Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethalityChelsea E Cunningham, Frederick S Vizeacoumar, Yue Zhang, et al.
Signal Transduction and Targeted Therapy|June 3, 2026
Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancersJared D W Price, Frederick S Vizeacoumar, Omar Abuhussein, et al.
Pageof 35

Showing results (331-340 of 350) with videos related to

Sort By:
Pageof 35
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 23, 2016
Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumorsJen-Chieh Lee, Sheng-Yao Su, Chun A Changou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 25, 2021
TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibitionSarah Chiang, Varshini Vasudevaraja, Jonathan Serrano, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian CancerKim Ma, Basile Tessier-Cloutier, Alon D Altman, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 2012
14-3-3 fusion oncogenes in high-grade endometrial stromal sarcomaCheng-Han Lee, Wen-Bin Ou, Adrian Mariño-Enriquez, et al.
The Journal of Pathology. Clinical Research|March 8, 2022
The impact of whole genome and transcriptome analysis (WGTA) on predictive biomarker discovery and diagnostic accuracy of advanced malignanciesBasile Tessier-Cloutier, Jasleen K Grewal, Martin R Jones, et al.
The New England Journal of Medicine|December 23, 2011
Recurrent somatic DICER1 mutations in nonepithelial ovarian cancersAlireza Heravi-Moussavi, Michael S Anglesio, S-W Grace Cheng, et al.
Nature|June 12, 2024
Obesity induces PD-1 on macrophages to suppress anti-tumour immunityJackie E Bader, Melissa M Wolf, Gian Luca Lupica-Tondo, et al.
Nature|July 9, 2024
Author Correction: Obesity induces PD-1 on macrophages to suppress anti-tumour immunityJackie E Bader, Melissa M Wolf, Gian Luca Lupica-Tondo, et al.
Cell Genomics|May 10, 2025
Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethalityChelsea E Cunningham, Frederick S Vizeacoumar, Yue Zhang, et al.
Signal Transduction and Targeted Therapy|June 3, 2026
Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancersJared D W Price, Frederick S Vizeacoumar, Omar Abuhussein, et al.
Pageof 35